Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
+7.65M
-
Total reported value, excl. options
-
$847M
-
Value change
-
+$177M
-
Put/Call ratio
-
0.6
-
Number of buys
-
97
-
Number of sells
-
-28
-
Price
-
$21.71
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q4 2020
144 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q4 2020.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
of 84.7M outstanding shares and own 46.06% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.72M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.37M shares), FRANKLIN RESOURCES INC (2.23M shares), RA CAPITAL MANAGEMENT, L.P. (2.12M shares), VANGUARD GROUP INC (1.92M shares), BVF INC/IL (1.85M shares), SV Health Investors, LLC (1.82M shares), BAILLIE GIFFORD & CO (1.7M shares), Samsara BioCapital, LLC (1.68M shares), and Point72 Asset Management, L.P. (1.41M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.